Bausch Health Companies (BHC) Debt to Equity (2009 - 2026)

Bausch Health Companies has disclosed Debt to Equity across 18 years of filings, most recently posting -$10.08 for Q1 2026.

• Debt to Equity for Q1 2026 came in at -$10.08, up 88.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.08 (up 88.75% YoY), and the FY2025 annual result was $55.22, up 426.72% from the prior year.
• Debt to Equity came in at -$10.08 for Q1 2026 at Bausch Health Companies, down from $55.22 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $147.88 in Q2 2025 to a low of -$273.02 in Q4 2023.
• The 5-year median for Debt to Equity is -$10.08 (2026), against an average of -$15.59.
• Across the five-year window, Debt to Equity slumped 441.84% in 2023 and surged 426.72% in 2025, its largest moves.
• Bausch Health Companies' Debt to Equity stood at $79.87 in 2022, then plunged by 441.84% to -$273.02 in 2023, then surged by 93.81% to -$16.9 in 2024, then soared by 426.72% to $55.22 in 2025, then plunged by 118.26% to -$10.08 in 2026.
• The last three Debt to Equity figures came in at -$10.08 (Q1 2026), $55.22 (Q4 2025), and $59.11 (Q3 2025), per Business Quant data.